TeraView is pleased to announce a newly granted US patent that covers a pioneering test system designed for devices with multiple electrical contacts, integrating a movable probe assembly and a sophisticated profile-determining system. This system ensures precise mapping and reliable testing of advanced 2.5/3D packaging used in chips for artificial intelligence (AI), machine learning as well […]

Following global commercial launch in September, Illumina Protein Prep’s “out of the box” solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed Sydney Mass Spectrometry is the first facility in the wider Asia Pacific region to offer Illumina Protein Prep, adding to a growing list of institutions revealing biological insights with exceptional […]

Toronto, Canada — HUPO World Congress — Evosep, a global leader in proteomics solutions, is proud to announce a new initiative at HUPO 2025 aimed at solving one of LCMS based proteomics most persistent challenges: sample preparation. Building on its legacy of standardizing proteomics LC separation, Evosep is now expanding upstream to deliver robust, and […]

The new development and production building (shown at top right) looks out over the existing production halls. The Endress+Hauser Group has opened a new development and production building for liquid analysis at its Waldheim site in Saxony, Germany. The family-owned company has had a presence in Waldheim since 1990 and has steadily grown its operations there […]

The company now has twice the space for developing and manufacturing liquid analysis sensors and components Endress+Hauser Liquid Analysis invested around 35 million euros in the new building, effectively doubling the Waldheim site’s usable floor area to over 18,000 square meters. The three-story annex houses new production facilities, a logistics center with a fully automated […]

SAN DIEGO — The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on November 10, Illumina remains on the Unreliable Entities List (UEL), requiring government approval for instrument purchases. Illumina remains focused […]

Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s next-generation single-molecule proteomics platform  Joint research results show high reproducibility across sites and insight into novel tau biology, signaling a fundamental shift in how proteomics technology can advance human health and longevity Data presentation at the 2025 HUPO World […]

ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sonoma Biotherapeutics has been awarded a $300,000 G-Rex® Grant. SonomaBio’s G-Rex® Grant will enable expeditious development of a G-Rex® based manufacturing process to produce gene-modified regulatory T cell (Treg) therapies for clinical investigation of SonomaBio products in development for various autoimmune related disorders. […]

Spin-off positions Solstice to accelerate growth and unlock shareowner value as a leading pure-play specialty materials company Poised to benefit from strong and resilient secular trends across cooling, building solutions, advanced computing, energy, safety and healthcare Begins trading today on Nasdaq under the ticker symbol “SOLS” MORRIS PLAINS, N.J. — Solstice Advanced Materials (NASDAQ: SOLS), […]

Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research Grants FREMONT, Calif. — Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. (Nasdaq: CTKB) is taking steps to ensure critical scientific research can continue. Joining the International […]